Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3093

Actual shortage: 246 (8%)
Anticipated shortage: 15 (0%)
Avoided shortage: 9 (0%)
Resolved: 2823 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-VARENICLINE 0.5MG TABLET Resolved 2020-12-18 2021-04-26 130416
APO-VARENICLINE 0.5MG 1MG KIT TABLET Resolved 2021-02-05 2021-03-01 133394
APO-VARENICLINE 1MG TABLET Resolved 2021-02-19 2021-02-26 134445
APO-VARENICLINE 1MG TABLET Actual shortage 2021-05-07 2022-02-03 138992
APO-VARENICLINE 0.5MG TABLET Resolved 2021-07-05 2021-08-30 141857
APO-VARENICLINE 1MG 0.5MG TABLET KIT Actual shortage 2021-11-29 2021-11-29 150175
APO-VARENICLINE 1MG TABLET Resolved 2023-04-21 2023-04-27 190014
APO-VARENICLINE 1MG TABLET Resolved 2023-05-12 2023-06-02 192364
APO-VARENICLINE 0.5MG TABLET Resolved 2023-05-26 2023-06-02 193227
APO-VARENICLINE 1MG TABLET Resolved 2023-11-06 2023-12-01 209366
APO-VARENICLINE 1MG TABLET Actual shortage 2024-04-19 2024-05-24 225764
APO-VARENICLINE 0.5MG TABLET Actual shortage 2024-05-31 2024-05-31 229427
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2017-05-16 2018-03-08 10442
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2017-07-25 2018-03-08 16886
APO-VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2017-09-27 2018-03-08 23658
APO-VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2018-04-10 2018-11-03 45353
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-05-31 2019-05-31 50971
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2018-12-12 2019-03-08 69458
APO-VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2018-12-12 2019-12-23 69460
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-04-18 2019-05-21 82022

Showing 2921 to 2940 of 3093

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-BRIMONIDINE 0.2% SOLUTION To be discontinued 2018-09-07 2018-09-07 60294
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2018-09-07 2018-12-28 60301
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2020-11-16 2020-11-16 128438
APO-BROMAZEPAM 1.5MG TABLET To be discontinued 2018-09-07 2018-09-07 60304
APO-BROMAZEPAM 3MG TABLET Discontinued 2018-09-07 2019-06-12 60307
APO-BROMAZEPAM 6MG TABLET Discontinued 2018-09-07 2018-10-19 60310
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60313
APO-CANDESARTAN 16MG TABLET Discontinued 2018-09-07 2018-09-15 60316
APO-CANDESARTAN 4MG TABLET Discontinued 2018-09-07 2018-09-15 60319
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60322
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60325
APO-CANDESARTAN 32MG TABLET Discontinued 2018-09-07 2018-09-15 60328
APO-CANDESARTAN/HCTZ 25MG 32MG TABLET Discontinued 2018-02-26 2018-05-03 41011
APO-CANDESARTAN/HCTZ 12.5MG 32MG TABLET Discontinued 2018-02-26 2018-02-26 41020
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-02-26 2018-02-26 41047
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60331
APO-CANDESARTAN/HCTZ 12.5MG 16.0MG TABLET Discontinued 2018-09-07 2018-09-15 60335
APO-CAPTO TAB 6.25MG 6.25MG TABLET Discontinued 2018-09-07 2019-06-12 60339
APO-CARVEDILOL 12.5MG TABLET To be discontinued 2024-01-26 2024-04-01 217493
APO-CARVEDILOL 3.125MG TABLET To be discontinued 2024-01-26 2024-01-26 217496

Showing 81 to 100 of 356